From: Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer
No. | Chip No. | Category | Histological type | Differentiation degree | TNM (clinical, 9th edition) | Stage (FIGO 2018) |
---|---|---|---|---|---|---|
1 | A1, 2 | 1: Carcinoma, 2: Adjacent normal tissues | Squamous cell carcinoma | Medium—low | T1b3N1M0 | IIIC1 |
2 | A3, 4 | 3: Carcinoma, 4: Adjacent normal tissues | Squamous cell carcinoma | Medium | T1b3N0M0 | IB3 |
3 | A5, 6 | 5: Carcinoma, 6: Adjacent normal tissues | Squamous cell carcinoma | Medium | T1b3N0M0 | IB3 |
4 | B1, 2 | 1: Carcinoma, 2: Adjacent normal tissues | Squamous cell carcinoma | Medium | T1b3N0M0 | IB3 |
5 | B3, 4 | 3: Carcinoma, 4: Adjacent normal tissues | Squamous cell carcinoma | Low | T1b2N0M0 | IB2 |
6 | B5, 6 | 5: Carcinoma, 6: Adjacent normal tissues | Squamous cell carcinoma | Medium–low | T1b2N1M0 | IIIC1 |
7 | C1, 2 | 1: Carcinoma, 2: Adjacent normal tissues | Squamous cell carcinoma | Low | T1b3N1M0 | IIIC1 |
8 | C3, 4 | 3: Carcinoma, 4: Adjacent normal tissues | Squamous cell carcinoma | Low | T1b2N0M0 | IB2 |
9 | C5, 6 | 5: Carcinoma, 6: Adjacent normal tissues | Squamous cell carcinoma | Medium–high | T1b2N0M0 | IB2 |
10 | D1, 2 | 1: Carcinoma, 2: Adjacent normal tissues | Squamous cell carcinoma | Low | T1b3N0M0 | IB3 |
11 | D3, 4 | 3: Carcinoma, 4: Adjacent normal tissues | Squamous cell carcinoma | Medium | T1b3N1M0 | IIIC1 |